Overview
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide and a met-enkephalin analog, notable for incorporating unnatural D-amino acids. Developed in the 1980s, it was among the first peptides discovered to stimulate growth hormone release through the ghrelin receptor pathway. Its ability to stimulate appetite and work synergistically with GHRH analogs makes it a valuable research tool.
The peptide functions as a growth hormone secretagogue, increasing growth hormone levels in the body by signaling the pituitary gland. Unlike growth hormone releasing hormone (GHRH), GHRP-6 operates through a distinct receptor, allowing concurrent use of both peptides for potentially synergistic effects. GHRP-6's other notable action is as an appetite stimulant.
GHRP-6 has been studied for its effects on growth hormone release, appetite stimulation, gastric motility, and potential cardioprotective properties, making it a compound of interest in endocrinology, metabolism research, and cardiac studies.
Mechanism of Action
GHRP-6 functions as an agonist of the ghrelin receptor (GHSR-1a), which leads to the stimulation of GH release from the pituitary gland. This mechanism is distinct from that of GHRH, allowing for synergistic effects when both are administered. GHRP-6 also stimulates hunger through its ghrelin-mimetic effects on appetite centers in the brain.
The peptide binds to the GHSR-1a receptor, triggering a cascade of intracellular signals that ultimately result in increased GH synthesis and secretion. This receptor is primarily located in the pituitary gland and hypothalamus but is also found in other tissues, which may contribute to the peptide's diverse effects. At higher doses, GHRP-6 may also stimulate the release of cortisol and prolactin, though to a lesser extent compared to some other GHRPs.
Key Benefits
- Stimulates growth hormone release
- Increases appetite
- May improve gastric motility
- Potential cardioprotective effects under research
Research & Indications
Research on GHRP-6 has demonstrated its ability to produce dose-dependent increases in growth hormone levels through direct activation of the GHSR-1a receptor on pituitary somatotroph cells. Studies show peak GH concentrations occurring shortly after subcutaneous administration. It has been researched in elderly subjects where natural GH production is diminished, making it potentially valuable for age-related growth hormone decline and sarcopenia prevention studies.
GHRP-6's ghrelin-mimetic activity leads to pronounced appetite stimulation, making it valuable for studying feeding behavior mechanisms and cachexia treatment approaches. Research indicates that GHRP-6 can increase food intake and body weight gain in anorexia and cancer-related cachexia models.
Emerging research suggests potential cardioprotective properties, with studies in ischemia-reperfusion injury models demonstrating reduced infarct size and improved left ventricular function. GHRP-6 has also been studied for effects on cardiac fibrosis.
Dosing Protocols
Disclaimer: The following dosing information is for research purposes only and does not constitute medical advice. Consult with a qualified healthcare professional before using GHRP-6 or any other peptide.
Research studies have used dosages ranging from 25 mcg to 300 mcg, typically administered 2-3 times daily. The peptide is commonly studied in combination with GHRH analogs for synergistic effects.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Growth Hormone Release | 25-300 mcg | 2-3 times daily | Subcutaneous |
Supplies Needed
For an 8-week protocol:
- Peptide Vials: 1-2 vials of 10mg each
- Insulin Syringes (U-100): 50 per week, 400 total
- Bacteriostatic Water: 1 × 10mL bottle
- Alcohol Swabs: One for vial + one for injection site daily
Side Effects & Safety
Common side effects of GHRP-6 may include increased appetite, mild water retention, and temporary injection site reactions. Some individuals may experience increased prolactin or cortisol levels, especially at higher doses. GHRP-6 is contraindicated in individuals with known hypersensitivity to the peptide or any of its components. Safety during pregnancy and breastfeeding has not been established.
Storage & Handling
Store lyophilized GHRP-6 at -20°C. Reconstituted solution should be stored at 2-8°C and used within a short period.